Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
about
Role of cholangiocytes in primary biliary cirrhosis.Autoimmunity: twenty years in the Fas laneTandem DEDs and CARDs suggest novel mechanisms of signaling complex assembly.Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker.Differential affinity of FLIP and procaspase 8 for FADD's DED binding surfaces regulates DISC assembly
P2860
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
@ast
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
@en
type
label
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
@ast
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
@en
prefLabel
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
@ast
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
@en
P2093
P2860
P356
P1476
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.
@en
P2093
Madhu Ramaswamy
Richard M Siegel
P2860
P2888
P304
P356
10.1038/NRRHEUM.2010.225
P407
P577
2011-02-01T00:00:00Z
P5875
P6179
1019444832